Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma

MLA

Erik R. Peterson, et al. “Purine Salvage Promotes Treatment Resistance in H3K27M-Mutant Diffuse Midline Glioma.” Cancer & Metabolism, vol. 12, no. 1, Apr. 2024, pp. 1–19. EBSCOhost, https://doi.org/10.1186/s40170-024-00341-7.

APA

Erik R. Peterson, Peter Sajjakulnukit, Andrew J. Scott, Caleb Heaslip, Anthony Andren, Kari Wilder-Romans, Weihua Zhou, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin, Alexandra O’Brien, Ayesha Kothari, Zitong Zhao, Li Zhang, Meredith A. Morgan, Sriram Venneti, Carl Koschmann, Nada Jabado, Costas A. Lyssiotis, … Daniel R. Wahl. (2024). Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma. Cancer & Metabolism, 12(1), 1–19. https://doi.org/10.1186/s40170-024-00341-7

Chicago

Erik R. Peterson, Peter Sajjakulnukit, Andrew J. Scott, Caleb Heaslip, Anthony Andren, Kari Wilder-Romans, Weihua Zhou, et al. 2024. “Purine Salvage Promotes Treatment Resistance in H3K27M-Mutant Diffuse Midline Glioma.” Cancer & Metabolism 12 (1): 1–19. doi:10.1186/s40170-024-00341-7.